News

Antibody-based Therapies May Trigger Brain Inflammation

New research suggests that brain inflammation is the likely reason antibody-based therapies are ineffective in clinical trials for people with Parkinson’s and Alzheimer’s diseases. The findings show that the binding of the antibody to its target protein — in the case of Parkinson’s disease the misfolded alpha-synuclein —…

Magnetic Nanoparticles May Help Restore Brain Function

Magnetic nanoparticles may help restore brain function by directing nerve cell growth, a new study shows. Researchers believe this technology has therapeutic potential and may be used in the development of new treatments for Parkinson’s disease, The study, “Magnetic spatiotemporal control of SOS1 coupled nanoparticles for guided neurite growth in…

MJFF Parkinson’s Policy Forum Aims to Restore US Research Funds to $25M

More than 350 disease advocates, representing all 50 U.S. states, took part in The Michael J. Fox Foundation (MJFF) virtual Parkinson’s Policy Forum, urging lawmakers to increase federal investment in Parkinson’s disease (PD) research after years of stagnant support. Annual funding for the Department of Defense’s Parkinson’s Research…